XORTX Therapeutics Inc. 6-K 文件发布
6-K - XORTX Therapeutics Inc. (0001729214) (Filer)
XORTX Therapeutics Inc. 发布 6-K 文件，披露公司财务信息。文件包含 2026 年 10 月的报告，由首席执行官 Allen Davidoff 签署。该文件为美国证券交易委员会提交的外国私人发行人报告。
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2026
Commission File Number: 001-40858
XORTX Therapeutics Inc.
3710 – 33rd Street NW, Calgary, Alberta, Canada T2L 2M1
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F [ X ] Form 40-F [ ]
EXHIBIT INDEX
| Exhibit | Description | |
| 99.1 | News release dated October 8, 2026. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| XORTX Therapeutics Inc. | |||
| Date: October 8, 2026 | By: | /s/ Allen Davidoff | |
| Name: | Allen Davidoff | ||
| Title: | Co-Chief Executive Officer | ||
来源：SEC EDGAR · 本站存档